Suzanne C. Schiffman, MD
Dr. Suzanne C. Schiffman is a surgical oncologist with the Allegheny Health Network in Pittsburgh, Pennsylvania. She specializes in treating patients with malignant peritoneal mesothelioma and other complex abdominal malignancies, including cancers of the bile duct, pancreas, liver, stomach, small bowel, colon, and peritoneum.[1]
Dr. Schiffman’s surgical skills include minimally invasive techniques, as well as the intricate procedure that combines cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Dr. Schiffman is dedicated to offering personalized solutions to her patients and prioritizes open communication and building trusting relationships.
Education and Career
Dr. Schiffman’s board certification in Surgery and Surgery Oncology follows years of medical education and training. She earned her medical degree at the Sidney Kimmel Medical College at Thomas Jefferson University and completed her internship and residency in General Surgery at the University of Louisville, where she served as administrative chief resident. Dr. Schiffman followed this experience with fellowships in both Surgical Oncology and Hepatobiliary Surgery at the University of Pittsburgh Medical Center.[1]
Research
Dr. Schiffman has participated in clinical trials and authored and co-authored several articles that have appeared in respected medical journals.
Her recent publications include:[3]
Characterizing the Immune Environment in Peritoneal Carcinomatosis: Insights for Novel Immunotherapy Strategies. Patrick L Wagner, Chelsea M Knotts, Vera S Donneberg, Neda Dadgar, Christian Cruz Pico, Kunhong Xiao, Ali Zaidi, Suzanne C Schiffman, Casey J Allen, Albert D Donnenber…>; Annals of Surgical Oncology. 2024 Mar 1[2]
Value implication of operative volume in delivering pancreatic cancer surgery within a health system. Jan 2023. C.J. Allen, K. Bowers C. Shen[…] D.L. Bartlett
Overutilization of PET-CT in the staging of pancreatic neoplasms. Jan 2023. C. Knotts, S. Falls, C. Allen[…] S. Schiffman
Defining the long-term values and quality of life of survivors of pancreaticoduodenectomy. Jan 2023. K. Bowers. C. Maxwell, S. Falls[…], C. Allen
S0045 Lung Metastasis in Pancreatic Cancer: Should Staging Chest CT Be Routinely Performed? Oct 2020. Talal Seoud, Aslam Syed, Shailendra Singh[…] Shyam Thakkar
Survival Trends for Resectable Pancreatic Cancer Using a Multidisciplinary Conference: The Impact of Post-operative Chemotherapy. Sep 2020. Aslam R. Syed, Neil Carleton, Zachary Horne[…], Shyam Thakkar. Purpose Despite advances in various treatment modalities, surgical resection for pancreatic ductal adenocarcinoma (PDA) remains the only curative treatment. Data remains limited regarding survival rates for resectable PDA when managed by a multidisciplinary pancreas conference (MDPC). This study aims to assess survival rates and identify signs…
A retrospective analysis of factors affecting palliative care consult in patients undergoing cytoreductive surgery and HIPEC. Feb 2020. Laila Babar, Herman Lo, Obaid Ashraf[…]Moses S. Raj. The National Cancer Institute defines palliative care as care given to improve the quality of life (QOL) for patients with life-threatening diseases. The role of palliative care (PC) within oncology is ever-evolving and as more studies are being conducted, its role in the improvement of QOL for patients is being widely recognized. P…
